 |
PDBsum entry 2oxd
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Chembiochem
8:1804-1809
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules.
|
|
R.Battistutta,
M.Mazzorana,
L.Cendron,
A.Bortolato,
S.Sarno,
Z.Kazimierczuk,
G.Zanotti,
S.Moro,
L.A.Pinna.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
CK2 is a highly pleiotropic Ser/Thr protein kinase that is able to promote cell
survival and enhance the tumour phenotype under specific circumstances. We have
determined the crystal structure of three new complexes with
tetrabromobenzimidazole derivatives that display K(i) values between 0.15 and
0.30 microM. A comparative analysis of these data with those of four other
inhibitors of the same family revealed the presence of some highly conserved
water molecules in the ATP-binding site. These waters reside near Lys68, in an
area with a positive electrostatic potential that is able to attract and orient
negatively charged ligands. The presence of this positive region and two unique
bulky residues that are typical of CK2, Ile66 and Ile174, play a critical role
in determining the ligand orientation and binding selectivity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.Cozza,
A.Bortolato,
and
S.Moro
(2010).
How druggable is protein kinase CK2?
|
| |
Med Res Rev,
30,
419-462.
|
 |
|
|
|
|
 |
N.Zhang,
and
R.Zhong
(2010).
Structural basis for decreased affinity of Emodin binding to Val66-mutated human CK2 alpha as determined by molecular dynamics.
|
| |
J Mol Model,
16,
771-780.
|
 |
|
|
|
|
 |
G.Cozza,
M.Mazzorana,
E.Papinutto,
J.Bain,
M.Elliott,
G.di Maira,
A.Gianoncelli,
M.A.Pagano,
S.Sarno,
M.Ruzzene,
R.Battistutta,
F.Meggio,
S.Moro,
G.Zagotto,
and
L.A.Pinna
(2009).
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
|
| |
Biochem J,
421,
387-395.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Bretner,
A.Najda-Bernatowicz,
M.Łebska,
G.Muszyńska,
A.Kilanowicz,
and
A.Sapota
(2008).
New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole.
|
| |
Mol Cell Biochem,
316,
87-89.
|
 |
|
|
|
|
 |
S.Sarno,
and
L.A.Pinna
(2008).
Protein kinase CK2 as a druggable target.
|
| |
Mol Biosyst,
4,
889-894.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |